Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Mar;17(2):140-52.
doi: 10.1053/j.ackd.2009.12.001.

Diagnosis and screening of autosomal dominant polycystic kidney disease

York Pei  1 , Terry Watnick
Affiliations
Review

Diagnosis and screening of autosomal dominant polycystic kidney disease

York Pei et al. Adv Chronic Kidney Dis. 2010 Mar.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of kidney failure and accounts for approximately 5% of ESRD population in the United States. The disorder is characterized by the focal and sporadic development of renal cysts, which increase in size and number with age. Mutations of PKD1 and PKD2 account for most of the cases. Although the clinical manifestations of both gene types overlap completely, PKD1 is associated with more severe disease than PKD2, with larger kidneys and earlier onset of ESRD. In general, renal ultrasonography is commonly used for the diagnosis of ADPKD, and age-dependent criteria have been defined for subjects at risk of PKD1. However, the utility of the PKD1 ultrasound criteria in the clinic setting is unclear because their performance characteristics have not been defined for the milder PKD2 and the gene type for most test subjects is unknown. Recently, highly predictive ultrasound diagnostic criteria have been derived for at-risk subjects of unknown gene type. Additionally, both DNA linkage or gene-based direct sequencing are now available for the diagnosis of ADPKD, especially in subjects with equivocal imaging results, subjects with a negative or indeterminate family history, or in younger at-risk individuals being evaluated as potential living-related kidney donors. Here, we review the clinical utilities and limitations of both imaging- and molecular-based diagnostic tests and outline our approach for the evaluation of individuals suspected to have ADPKD.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: Under a licensing agreement between Athena Laboratories and the Johns Hopkins University, Dr. Watnick and her spouse are entitled to a share of royalty received by the University on sales of products described in this article. They have elected to donate their share of the royalty to the Polycystic Kidney Disease Research Foundation. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies.

Figures

Figure 1
Figure 1
The pre-test probability of disease decreases with age in subjects born with 50% risk of ADPKD and differs between PKD1 and PKD2. (A) The prevalence of PKD1 (solid color) and PKD2 (strip color) are assumed to be 85% and 15%, respectively. At birth, the proportion of affected but clinically undiagnosed subjects (green color) is equal to that of at-risk but unaffected subjects (blue color). With increasing age the proportion of affected but clinically undiagnosed subjects (green color) diminishes as increasing proportion of the affected subjects are clinically diagnosed (yellow color). However, a higher proportion of the more severely affected PKD1 subjects will be clinically diagnosed (solid yellow color) compared to affected PKD2 subjects (strip yellow color). (B) The pre-test probability of disease among subjects born with 50% risk for PKD1 (circle) and PKD2 (diamond) diverges with increasing age (Data derived from Lancet 353: 103-7, 1999).
Figure 2
Figure 2
(A) T2 weighted breath-held MRI from a 28 year-old female at-risk of ADPKD performed without contrast injection in one breath-hold showing multiple tiny cysts in a cortical and perihilar distribution (white arrows) in both kidneys (≫10/kidney). (B) Corresponding ultrasound through both kidneys was normal. Only the left kidney ultrasound is shown. DNA testing subsequently detected a truncating PKD2 mutation in her and her other affected family members.
Figure 3
Figure 3
Molecular genetic evaluation of III:3, who had a negative renal ultrasound, as a potential living-related kidney donor. Direct sequencing of PKD1 and PKD2 in her affected father (II:2) identified two unclassifiable PKD1 variants (Q739R and del2763M) of uncertain clinical significance. Although III:3 did not carry these variants, the mutation analysis was considered as indeterminate. Haplotype analysis, on the other hand, showed that only the PKD1 haplotype 3-2-2-3-1 (upper panel), but no single PKD2 haplotype (lower panel), co-segregated with the affected family members indicating that this family was PKD1-linked. Since III:3 did not carry this putative PKD1 disease haplotype, she was considered as unaffected (adapted from C J Am Soc Nephrol 3: 146-52, 2008).
Figure 4
Figure 4
Diagnostic algorithm for the evaluation of an individual suspected to have ADPKD. See text for details.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med. 1993;329:332–342. - PubMed
    1. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis. 1983;2:630–639. - PubMed
    1. Davies F, Coles GA, Harper PS, Williams AJ, Evans C, Cochlin D. Polycystic kidney disease re-evaluated: a population-based study. Q J Med. 1991;79:477–485. - PubMed
    1. Peters DJ, Sandkuijl LA. Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol. 1992;97:128–139. - PubMed
    1. Dobin A, Kimberling WJ, Pettinger W, Bailey-Wilson JE, Shugart YY, Gabow P. Segregation analysis of autosomal dominant polycystic kidney disease. Genet Epidemiol. 1993;10:189–200. - PubMed

Publication types

MeSH terms